These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19971387)

  • 21. Production of high titre antibody response against Russell's viper venom in mice immunized with ethanolic extract of fruits of Piper longum L. (Piperaceae) and piperine.
    Shenoy PA; Nipate SS; Sonpetkar JM; Salvi NC; Waghmare AB; Chaudhari PD
    Phytomedicine; 2014 Jan; 21(2):159-63. PubMed ID: 24060214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioinformatics and multiepitope DNA immunization to design rational snake antivenom.
    Wagstaff SC; Laing GD; Theakston RD; Papaspyridis C; Harrison RA
    PLoS Med; 2006 Jun; 3(6):e184. PubMed ID: 16737347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of Nanobodies Against Hemorrhagic and Myotoxic Components of
    Bailon Calderon H; Yaniro Coronel VO; Cáceres Rey OA; Colque Alave EG; Leiva Duran WJ; Padilla Rojas C; Montejo Arevalo H; García Neyra D; Galarza Pérez M; Bonilla C; Tintaya B; Ricciardi G; Smiejkowska N; Romão E; Vincke C; Lévano J; Celys M; Lomonte B; Muyldermans S
    Front Immunol; 2020; 11():655. PubMed ID: 32457735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Venom Ophthalmia and Ocular Complications Caused by Snake Venom.
    Chang KC; Huang YK; Chen YW; Chen MH; Tu AT; Chen YC
    Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32911777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring snake venom proteomes: multifaceted analyses for complex toxin mixtures.
    Fox JW; Serrano SM
    Proteomics; 2008 Feb; 8(4):909-20. PubMed ID: 18203266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Macrovipera lebetina obtusa Snake Venom as a Modulator of Antitumor Effect in S-180 Sarcoma Mouse Model].
    Ghazaryan N; Movsisyan N; Macedo JC; Vaz S; Ayvazyan N; Pardo L; Logarinho E
    Mol Biol (Mosk); 2021; 55(3):468-477. PubMed ID: 34097681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Snake venom as therapeutic agents: from toxin to drug development.
    Pal SK; Gomes A; Dasgupta SC; Gomes A
    Indian J Exp Biol; 2002 Dec; 40(12):1353-8. PubMed ID: 12974396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of venom gene homologs in diverse python tissues suggests a new model for the evolution of snake venom.
    Reyes-Velasco J; Card DC; Andrew AL; Shaney KJ; Adams RH; Schield DR; Casewell NR; Mackessy SP; Castoe TA
    Mol Biol Evol; 2015 Jan; 32(1):173-83. PubMed ID: 25338510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative cost and efficacy trial of Pakistani versus Indian anti snake venom.
    Qureshi H; Alam SE; Mustufa MA; Nomani NK; Asnani JL; Sharif M
    J Pak Med Assoc; 2013 Sep; 63(9):1129-32. PubMed ID: 24601191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of venom-antivenom (VAV) immunocomplexes in vitro as a measure of antivenom efficacy.
    O'Leary MA; Isbister GK
    Toxicon; 2014 Jan; 77():125-32. PubMed ID: 24252422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tiger snake (Notechis spp) envenoming: Australian Snakebite Project (ASP-13).
    Isbister GK; O'Leary MA; Elliott M; Brown SG
    Med J Aust; 2012 Aug; 197(3):173-7. PubMed ID: 22860796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reappraisal of Vipera aspis venom neurotoxicity.
    Ferquel E; de Haro L; Jan V; Guillemin I; Jourdain S; Teynié A; d'Alayer J; Choumet V
    PLoS One; 2007 Nov; 2(11):e1194. PubMed ID: 18030329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lachesis stenophrys venom reduces the equine antibody response towards Bothrops asper venom used as co-immunogen in the production of polyspecific snake antivenom.
    Arroyo C; Solano S; Herrera M; Segura Á; Estrada R; Vargas M; Villalta M; Gutiérrez JM; León G
    Toxicon; 2015 Sep; 103():99-105. PubMed ID: 26100664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathophysiological significance and therapeutic applications of snake venom protease inhibitors.
    Thakur R; Mukherjee AK
    Toxicon; 2017 Jun; 131():37-47. PubMed ID: 28288936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Venom yield of the North American coral snake and its clinical significance.
    Fix JD
    South Med J; 1980 Jun; 73(6):737-8. PubMed ID: 7394594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of antivenom against the procoagulant effect of Australian brown snake (Pseudonaja sp.) venom: in vivo and in vitro studies.
    Isbister GK; O'Leary MA; Schneider JJ; Brown SG; Currie BJ;
    Toxicon; 2007 Jan; 49(1):57-67. PubMed ID: 17055016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzyme-linked immunosorbent assay of venom-antibodies in human victims of snake bite.
    Theakston RD; Pugh RN; Reid HA
    J Trop Med Hyg; 1981 Jun; 84(3):109-12. PubMed ID: 7241624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the venom of Oxyuranus microlepidotus.
    Morrison J; Pearn J; Covacevich J; Tanner C; Coulter A
    J Toxicol Clin Toxicol; 1983-1984; 21(3):373-85. PubMed ID: 6676477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of snake venom allergens by two-dimensional electrophoresis followed by immunoblotting.
    Hu Y; Yang L; Yang H; He S; Wei JF
    Toxicon; 2017 Jan; 125():13-18. PubMed ID: 27867095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hugh Alistair Reid OBE MD: investigation and treatment of snake bite.
    Hawgood BJ
    Toxicon; 1998 Mar; 36(3):431-46. PubMed ID: 9637363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.